Fibroblast growth factor (FGF) family ligands

Infigratinib phosphate (BGJ-398 phosphate NVP-BGJ398 phosphate) is a potent inhibitor of the FGFR family with IC 50 of 0.9 nM, 1.4 nM, 1 nM, and 60 nM for FGFR1 , FGFR2 , FGFR3 , and FGFR4 , respectively.In VitroInfigratinib phosphate inhibits

Infigratinib phosphate (BGJ-398 phosphate NVP-BGJ398 phosphate) is a potent inhibitor of the FGFR family with IC 50 of 0.9 nM, 1.4 nM, 1 nM, and 60 nM for FGFR1 , FGFR2 , FGFR3 , and FGFR4 , respectively.In VitroInfigratinib phosphate inhibits

Vosoritide (BMN 111) acetate is a natriuretic peptide receptor 2 ( NPR2 ) agonist that acts on the proliferation and differentiation of chondrocytes to promote bone growth.Appearance:SolidIn Vitro:Vosoritide (0.1 μM 1 h) acetate decreases NPR2

Vosoritide (BMN 111) acetate is a natriuretic peptide receptor 2 ( NPR2 ) agonist that acts on the proliferation and differentiation of chondrocytes to promote bone growth.Appearance:SolidIn Vitro:Vosoritide (0.1 μM 1 h) acetate decreases NPR2

Vosoritide (BMN 111) acetate is a natriuretic peptide receptor 2 ( NPR2 ) agonist that acts on the proliferation and differentiation of chondrocytes to promote bone growth.Appearance:SolidIn Vitro:Vosoritide (0.1 μM 1 h) acetate decreases NPR2

VSPPLTLGQLLS is a small peptide FGFR3 inhibitor, peptide P3, inhibits FGFR3 phosphorylation. VSPPLTLGQLLS inhibits 9-cisRA-induced tracheal lymphangiogenesis and blocks lymphatic endothelial cell (LEC) proliferation, migration, and tubule

VSPPLTLGQLLS is a small peptide FGFR3 inhibitor, peptide P3, inhibits FGFR3 phosphorylation. VSPPLTLGQLLS inhibits 9-cisRA-induced tracheal lymphangiogenesis and blocks lymphatic endothelial cell (LEC) proliferation, migration, and tubule

VSPPLTLGQLLS is a small peptide FGFR3 inhibitor, peptide P3, inhibits FGFR3 phosphorylation. VSPPLTLGQLLS inhibits 9-cisRA-induced tracheal lymphangiogenesis and blocks lymphatic endothelial cell (LEC) proliferation, migration, and tubule